Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
Information source: University of Illinois at Chicago
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Subarachnoid Hemorrhage; Intracerebral Hemorrhage
Intervention: Nicardipine and Nipride (Drug)
Phase: N/A
Status: Completed
Sponsored by: University of Illinois at Chicago Official(s) and/or principal investigator(s):
Ben Z Roitberg, MD, Principal Investigator, Affiliation: University of Illinois at Chicago, Department of Neurosurgery
Summary
The purpose of this research is to explore ways to improve and simplify control of blood
pressure in patients with SAH or ICH. This research will be done by comparing tow different
medications that are routinely used to help control blood pressure. None of the medications
used in this study nor any procedures performed are experimental.
Clinical Details
Study design: Observational Model: Defined Population, Time Perspective: Longitudinal
Eligibility
Minimum age: 18 Years.
Maximum age: 70 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 18-70 years old (inclusive)
- Admission to NSICU with a diagnosis of SAH or ICH
Exclusion Criteria:
- Patients who are admitted >48 hours after SAH or ICH
- Readmission or second SAH
- Readmission or second ICH
- Large (immediately life threatening) associated intraparenchymal or intraventricular
hemorrhage
- Women who are pregnant
Locations and Contacts
University of Illinois at Chicago, UIC, Chicago, Illinois 60612, United States
Additional Information
Starting date: June 2004
Last updated: June 21, 2007
|
